In a significant medical breakthrough, Long Island's Sebastien Beauzile has become the first person in New York to be cured of sickle cell anemia, a genetic disease that causes chronic pain and a host of other health issues, primarily affecting people of African, Mediterranean, and Middle Eastern descent.
Beauzile, 21, endured the pain and complications of the disease since he was an infant, but with the help of a new genetic treatment known as Lyfgenia, he can now look forward to a future without the illness that has shadowed his life for 21 years, his mother Magda Lamour and him expressing immense gratitude to the medical team at Cohen Children's Medical Center for their work, according to an interview with CBS News New York.
The revolutionary therapy utilized Beauzile's own bone marrow in IV transfusions to create normal red blood cells, marking a historic moment in the long-standing battle against sickle cell disease; Dr. Jonathan Fish, from the medical center, emphasized the significance of the therapy, which involves correcting dysfunctional sickle cells by inserting the Lyfgenia gene.
Beauzile's achievement was celebrated at Cohen Children's Medical Center where he described the experience as a second birthday and a transformation into a new man saying “I’m Unstoppable,” and shared his aspirations of working in the medical field, acknowledging the team for altering the course of his life, this was shared with PIX11.
Civil rights attorney Benjamin Crump has contributed $100,000 to Northwell Health, supporting the organization's continuing efforts in treating sickle cell disease, a move that signifies hope for the availability of the gene therapy for the tens of thousands who suffer from the illness, especially in African nations where the disease is prevalent.
